This study found that a commercial digoxin capsule has inadequate bioavailability, differing from previous research. Bioavailability was similar between capsules and tablets in single-dose and steady-state trials.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: